Method for preparing almotriptan malate
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- YANGTZE RIVER PHARM GRP SICHUAN HAIRONG PHARM CO LTD
- Publication Date
- 2012-12-19
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of medicinal chemical synthesis, in particular to a preparation method of almotriptan malate. Background technique
[0002] Almotriptan malate, chemical name is 3-[2-(dimethylamino)ethyl]-5-(1-pyrrolidinylsulfonylmethyl)-1H-indole malate , is a migraine treatment drug for adolescents and adults. It was first listed in Spain in September 2000, and was approved by the US FDA in May 2001 for the treatment of adult migraine.
[0003] Almotriptan malate is a brand-new chemically synthesized compound. There are not many synthetic methods reported in the literature. Almost all synthetic routes start from p-aminobenzenesulfonylpyrrole (compound II), and then obtain through different methods. Target compound:
[0004]
[0005] For example, the method described in ES2084560 is a synthetic method originally reported by the original manufacturer. The compound II is diazotized to obtain the corresponding hydrazine, and then a...